Track the latest Artiva Biotherapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Artiva Biotherapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Jul 24, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund LPRA Capital Nexus Fund III LPPeter KolchinskyRajeev Shah | DIRECTOR | 9.85M | $11.91 | $104.71M | BUY | ∞ | 826.83K | Jul 22 | View |
Jul 24, 2024 | AM Partners VI LLCAM Ventures VI LPAM Opportunities II GP LLCAM Opportunities II LPKUSH PARMARAndrew Schwab | 10% OWNER | 2.35M | $11.36 | $14.71M | BUY | ∞ | 1.18M | Jul 22 | View |
Jul 22, 2024 | venBio Global Strategic Fund III LPVENBIO GLOBAL STRATEGIC GP III LPVENBIO GLOBAL STRATEGIC GP III LTDRobert AdelmanCOREY GOODMAN | — | 1.94M | $12.00 | $5.00M | BUY | ∞ | 1.94M | Jul 22 | View |
Jul 22, 2024 | GC CorpGC Cell Corp | 10% OWNER | 3.99M | $11.62 | $30.61M | BUY | ∞ | 1.26M | Jul 22 | View |
Jul 22, 2024 | YongJun Huh | — | 3.99M | $11.62 | $30.61M | BUY | ∞ | 1.26M | Jul 22 | View |
Browse insider trades on all stocks.